Chemed (NYSE:CHE – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Several other research firms have also issued reports on CHE. Royal Bank of Canada upped their price target on shares of Chemed from $604.00 to $712.00 and gave […]